Look at GERN as an example…..I was in that stock ….they had a product that was suppose to be a game changer….but they only really had that one product….they decided to GIA and the revenues just weren’t there nor did they improve much over the following year or so….look at the sp….uncy has olc and another in the pipeline but may be years away….if Uncy GIA and olc isn’t what its cut out to be revenue profit wise do you think Uncy sp will reach the historical predictions over the past year or two….they need to solicit…inquire ….other larger pharmaceutical to buy them…..so a for sale sign out front of there new Mountain View building would be helpful
Market Data 
Markets 
AI
